Sws Partners Merck & Co., Inc. Transaction History

Sws Partners

$310 Million
Q3 2024

A detailed history of Sws Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sws Partners holds 19,659 shares of MRK stock, worth $1.95 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

19,659

Previous 19,179 2.5%

Holding current value

$1.95 Million

Previous $2.37 Million 5.98%

% of portfolio

0.72%

Previous 0.72%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$111.15 - $128.97 $53,352 - $61,905	480 Added 2.5%	19,659 $2.23 Million
Q2 2024 Jul 17, 2024	SELL	$123.8 - $132.96 $157,226 - $168,859	-1,270 Reduced 6.21%	19,179 $2.37 Million
Q1 2024 Apr 30, 2024	SELL	$113.24 - $131.95 $325,451 - $379,224	-2,874 Reduced 12.32%	20,449 $2.7 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $93,067 - $101,279	929 Added 4.15%	23,323 $2.54 Million
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $153,601 - $170,580	1,492 Added 7.14%	22,394 $2.31 Million
Q2 2023 Aug 17, 2023	SELL	$108.61 - $118.38 $15.2 Million - $16.6 Million	-140,344 Reduced 87.04%	20,902 $2.41 Million
Q2 2023 Aug 10, 2023	BUY	$108.61 - $118.38 $15.2 Million - $16.6 Million	140,344 Added 671.44%	161,246 $18.6 Million
Q2 2023 Jul 26, 2023	SELL	$108.61 - $118.38 $125,661 - $136,965	-1,157 Reduced 5.25%	20,902 $2.41 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $116,322 - $129,791	-1,130 Reduced 4.87%	22,059 $2.35 Million
Q4 2022 Jan 30, 2023	BUY	$87.44 - $112.11 $44,157 - $56,615	505 Added 2.23%	23,189 $2.59 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $10,143 - $11,395	120 Added 0.53%	22,684 $1.95 Million
Q2 2022 Jul 28, 2022	SELL	$83.49 - $94.64 $630,933 - $715,194	-7,557 Reduced 25.09%	22,564 $2.06 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $5,660 - $6,344	77 Added 0.26%	30,121 $2.47 Million
Q4 2021 Jan 25, 2022	BUY	$72.28 - $90.54 $8,745 - $10,955	121 Added 0.4%	30,044 $2.3 Million
Q3 2021 Nov 08, 2021	BUY	$71.68 - $78.83 $522,188 - $574,276	7,285 Added 32.18%	29,923 $2.25 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $66,161 - $73,181	941 Added 4.34%	22,638 $1.76 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $802,287 - $945,012	-11,651 Reduced 34.94%	21,697 $1.67 Million
Q4 2020 Mar 31, 2021	BUY	$71.77 - $79.65 $304,376 - $337,795	4,241 Added 14.57%	33,348 $2.73 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $296,452 - $336,030	4,051 Added 16.17%	29,107 $2.41 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $62,885 - $71,556	893 Added 3.7%	25,056 $2.01 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $11,468 - $15,895	-181 Reduced 0.74%	24,163 $1.86 Million
Q3 2019 Nov 21, 2019	SELL	$76.08 - $82.93 $28.9 Million - $31.5 Million	-379,249 Reduced 93.97%	24,344 $2.07 Million
Q3 2019 Nov 15, 2019	BUY	$76.08 - $82.93 $28.9 Million - $31.5 Million	379,668 Added 1586.91%	403,593 $33.7 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $154,974 - $181,048	-2,219 Reduced 8.49%	23,925 $1.98 Million
Q4 2018 Feb 04, 2019	SELL	$65.24 - $75.71 $670,210 - $777,768	-10,273 Reduced 28.21%	26,144 $2 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $33,229 - $39,075	-576 Reduced 1.56%	36,417 $3.24 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $455,335 - $534,971	8,958 Added 31.95%	36,993 $2.25 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $55,699 - $64,738	-1,093 Reduced 3.75%	28,035 $1.49 Million
Q4 2017 Feb 15, 2018	BUY	$51.62 - $61.64 $1.5 Million - $1.8 Million	29,128	29,128 $1.64 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

News

Stay updated on Sws Partners with notifications on news.

Account